Cancer Research Meeting Calendar  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 2039-2044, May 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Briand, P.
Right arrow Articles by Petersen, O. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Briand, P.
Right arrow Articles by Petersen, O. W.

Trisomy 7p and Malignant Transformation of Human Breast Epithelial Cells following Epidermal Growth Factor Withdrawal1

Per Briand2, Kirsten Vang Nielsen, Mogens Winkel Madsen and Ole William Petersen

Department of Tumor Endocrinology, Division for Cancer Biology, The Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark [P. B., M. W. M.]; Department of Medical Genetics, Institute of Medical Biochemistry and Genetics [K. V. N.], and Structural Cell Biology Unit, Department of Anatomy, Section A [O. W. P.], The Panum Institute, University of Copenhagen, Denmark

We have reported previously on the first spontaneously immortalized, nonmalignant human breast epithelial cell line, HMT-3522, which is entirely dependent on exogenous epidermal growth factor (EGF). In passage 118, cells were adapted to grow in medium without EGF and a new growth-transformed subline, HMT-3522/gt-1, was generated and propagated at high growth rate without exogenous EGF (Madsen et al., Cancer Res., 52: 1210–1217, 1992). Here we have used this subline and the continuum of the parent line, HMT-3522/wt, to pose the question whether a relevant change in a physiological parameter of the microenvironment will induce malignant transformation. The two cell lines were cultured under identical conditions with the only exception that EGF was omitted in the medium for gt-1. Initially, wt and gt-1 were identical in terms of karyotype as well as morphology, growth rate, and protein expression as revealed by two-dimensional gel electrophoresis. A highly dramatic shift in phenotype was observed in passage 238 when the gt-1 line became tumorigenic in nude mice. After two mouse-culture passages, the resulting malignantly transformed cell line (HMT-3522/mt-1) was refractory to the growth-modulating effect of EGF and presented an extra copy of a chromosome marker, 7q-, as the only cytogenetic difference from the gt-1. Our results suggest that microenvironmental cues are powerful factors in the induction of malignancy. A major role of EGF receptor in the malignant transformation is emphasized by loss of EGF sensitivity and acquisition of an extra chromosome 7p harboring the EGF receptor gene. We hypothesize that during premalignant hyperplasia, a population of EGF/transforming growth factor {alpha} autonomous epithelial cells in situ may develop as a consequence of local transforming growth factor {alpha} deprivation, a condition reflected in the culture model as autonomy after EGF withdrawal.

1 This work was supported by the Danish Cancer Society, the Gangsted Foundation, the Haensch Foundation, the Novo-Nordic Foundation, the Mrs. Astrid Thaysen Foundation, the Velux Foundation, the Else and Mogens Wedell-Wedellsborg Foundation, the Willumsen Foundation, and the Birthe and John Meyer Foundation.

2 To whom requests for reprints should be addressed.

Received 11/17/95. Accepted 3/ 4/96.




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Rizki, V. M. Weaver, S.-Y. Lee, G. I. Rozenberg, K. Chin, C. A. Myers, J. L. Bascom, J. D. Mott, J. R. Semeiks, L. R. Grate, et al.
A Human Breast Cell Model of Preinvasive to Invasive Transition
Cancer Res., March 1, 2008; 68(5): 1378 - 1387.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Rizki, J. D. Mott, and M. J. Bissell
Polo-like Kinase 1 Is Involved in Invasion through Extracellular Matrix
Cancer Res., December 1, 2007; 67(23): 11106 - 11110.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
G. Chandramouly, P. C. Abad, D. W. Knowles, and S. A. Lelievre
The control of tissue architecture over nuclear organization is crucial for epithelial cell fate
J. Cell Sci., May 1, 2007; 120(9): 1596 - 1606.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Sandal, K. Valyi-Nagy, V. A. Spencer, R. Folberg, M. J. Bissell, and A. J. Maniotis
Epigenetic Reversion of Breast Carcinoma Phenotype Is Accompanied by Changes in DNA Sequestration as Measured by AluI Restriction Enzyme
Am. J. Pathol., May 1, 2007; 170(5): 1739 - 1749.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. W. Knowles, D. Sudar, C. Bator-Kelly, M. J. Bissell, and S. A. Lelievre
Automated local bright feature image analysis of nuclear protein distribution identifies changes in tissue phenotype
PNAS, March 21, 2006; 103(12): 4445 - 4450.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Liu, D. C. Radisky, C. M. Nelson, H. Zhang, J. E. Fata, R. A. Roth, and M. J. Bissell
Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.
PNAS, March 14, 2006; 103(11): 4134 - 4139.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. J. Maniotis, K. Valyi-Nagy, J. Karavitis, J. Moses, V. Boddipali, Y. Wang, R. Nunez, S. Setty, Z. Arbieva, M. J. Bissell, et al.
Chromatin Organization Measured by AluI Restriction Enzyme Changes with Malignancy and Is Regulated by the Extracellular Matrix and the Cytoskeleton
Am. J. Pathol., April 1, 2005; 166(4): 1187 - 1203.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
M.J. BISSELL, P.A. KENNY, and D.C. RADISKY
Microenvironmental Regulators of Tissue Structure and Function Also Regulate Tumor Induction and Progression: The Role of Extracellular Matrix and Its Degrading Enzymes
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 343 - 356.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. C. Park, R. L. Henshall-Powell, A. C. Erickson, R. Talhouk, B. Parvin, M. J. Bissell, and M. H. Barcellos-Hoff
Ionizing radiation induces heritable disruption of epithelial cell interactions
PNAS, September 16, 2003; 100(19): 10728 - 10733.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K. L. Schmeichel and M. J. Bissell
Modeling tissue-specific signaling and organ function in three dimensions
J. Cell Sci., June 15, 2003; 116(12): 2377 - 2388.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Anders, R. Hansen, R.-X. Ding, K. A. Rauen, M. J. Bissell, and W. M. Korn
Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor
PNAS, February 18, 2003; 100(4): 1943 - 1948.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
O. W. Petersen, H. L. Nielsen, T. Gudjonsson, R. Villadsen, F. Rank, E. Niebuhr, M. J. Bissell, and L. Ronnov-Jessen
Epithelial to Mesenchymal Transition in Human Breast Cancer Can Provide a Nonmalignant Stroma
Am. J. Pathol., February 1, 2003; 162(2): 391 - 402.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Muschler, D. Levy, R. Boudreau, M. Henry, K. Campbell, and M. J. Bissell
A Role for Dystroglycan in Epithelial Polarization: Loss of Function in Breast Tumor Cells
Cancer Res., December 1, 2002; 62(23): 7102 - 7109.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
F. Wang, R. K. Hansen, D. Radisky, T. Yoneda, M. H. Barcellos-Hoff, O. W. Petersen, E. A. Turley, and M. J. Bissell
Phenotypic Reversion or Death of Cancer Cells by Altering Signaling Pathways in Three-Dimensional Contexts
J Natl Cancer Inst, October 2, 2002; 94(19): 1494 - 1503.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. D. Zantek, J. Walker-Daniels, J. Stewart, R. K. Hansen, D. Robinson, H. Miao, B. Wang, H.-J. Kung, M. J. Bissell, and M. S. Kinch
MCF-10A-NeoST: A New Cell System for Studying Cell-ECM and Cell-Cell Interactions in Breast Cancer
Clin. Cancer Res., November 1, 2001; 7(11): 3640 - 3648.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H.-M. Chen, K. L. Schmeichel, I. S. Mian, S. Lelièvre, O. W. Petersen, and M. J. Bissell
AZU-1: A Candidate Breast Tumor Suppressor and Biomarker for Tumor Progression
Mol. Biol. Cell, April 1, 2000; 11(4): 1357 - 1367.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Wang, V. M. Weaver, O. W. Petersen, C. A. Larabell, S. Dedhar, P. Briand, R. Lupu, and M. J. Bissell
Reciprocal interactions between beta 1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology
PNAS, December 8, 1998; 95(25): 14821 - 14826.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
V.M. Weaver, O.W. Petersen, F. Wang, C.A. Larabell, P. Briand, C. Damsky, and M.J. Bissell
Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies
J. Cell Biol., April 7, 1997; 137(1): 231 - 245.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.